Gavi, the Vaccine Alliance, has reported the efforts of some African researchers to develop new drugs from the continent’s vast natural biodiversity using Artificial Intelligence.
Gavi, referring to an interview with SciDev.Net, an organisation that publishes news, views and analysis about science and technology for global development, confirmed the efforts of the group as narrated by the lead researcher, Fidele Ntie-Kang, an associate professor at the University of Buea in Cameroon.
Mr Ntie-Kang said his team is deploying AI to screen hundreds of natural compounds to find effective remedies for globally neglected diseases.
